Vitrification of oocytes

The vitrification of oocytes allows women to preserve their fertility and postpone pregnancy to a later date.

What is vitrification?

When is it recommended?

As a fertility preservation method, oocyte vitrification is recommended on the same basis as any other fertility preservation treatment:

  • Women who wish to have children at a later date
  • Women who have been diagnosed with cancer or other conditions which require gonadotoxic treatments
  • Women who have had repeated ovarian surgery (for example in the case of endometriosis)
  • Patients for whom we recommend carrying out embryo transfer in a later cycle: This may be recommended if there is a risk of OHSS, development of polyps, hydrosalpinx or hydrometra, absence of sperm, etc.
  • Patients who have a poor response or previously failed treatment: If pre-implantation genetic diagnosis is recommended, a sufficient quantity of oocytes will need to be obtained and vitrified.

For over 30 years, IVI has helped more than 200,000 dreams come true.


97% of our patients recommend IVI. We’re with you at every stage of your treatment, providing support and care.


IVI has a worldwide reputation for innovative research and has developed and patented pioneering techniques and technologies.


IVI is one of the largest fertility treatment providers in the world, with more than 65 clinics in 9 countries.




Oocyte vitrification for cancer patients

Oocyte vitrification for cancer patients

Request your first appointment

Back to toparrow_drop_up